Pharma & Biotech – AI.RadicalShift

interviewsVery Long Interview with Grok 3 on AI: The Great Handover: How AI is Reshaping Our World

Accelerated computing, Agent AI, AI assistants, AI models, Algorithms, Americas, Artificial Intelligence, Augmented reality, Automotive, Autonomous driving, Aviation & Aerospace, Chemicals, Datasets, Deep learning, Defence, Edge AI, Edge computing, Electronics & Machinery, Energy, Gas & Oil, Entertainment, Environment, Financial, Gaming, Generative AI, Graph neural network (GNN), Graphics Processing Unit (GPU), Healthcare, Internet & Online, LLMs (Large Language Models), Machine learning, Natural language processing (NLP), Neural networks, Pharma & Biotech, Quantum Computing, Science, Security & Safety, Semiconductors

March 14, 2025

Oleg Lazarov

2nm chips, Adobe’s AI, agentic AI, AGI, AI, AIVA’s tracks, Apple M-series, Apple’s Neural Engine, Apple’s Secure Enclave, AR, AutoGPT, automation, AWS SageMaker, biases, Black Box Blues, brain-computer interfaces (BCI), brain-signal-to-text, cancer patients, carbon-neutral cities, Cerebras, chain-of-thought, chain-of-thought reasoning, chiplets, CLIP, convolutional neural networks, creative collaboration, creativity, data synthesis, decision trees, decision-making, deep learning, Drug Discovery, Duolingo, edge AI, Edge chips, Education, energy efficiency, EU AI Act, Explainable AI, FedAvg, federated learning, generative adversarial networks (GANs), Georgia State’s AI system, GitHub, Google, Google’s DeepMind, Google’s VideoLLM, GPT-4, GPUs, Grok, Grok 3, Grok’s Toolkit, H200, hallucinations, Healthcare, high bandwidth memory (HBM3), HIPAA compliance, homomorphic encryption, human oversight, IBM, IBM Watson Health, IBM’s AI Fairness 360, innovation, Jasper, jobocalypse, Khan Academy, linear regression, LLMs, machine learning, March 14 2025, Meta, Meta’s SeamlessM4T, Microsoft’s Copilot, Midjourney, Mixture of Experts, modern AI, MS COCO, multimodal AI, natural language processing (NLP), Nest, neural networks, neuromorphic processors, No Man’s Sky, NVIDIA’s DLSS, NVIDIA’s Jetson, NVLink, OpenAI o1, OpenAI’s GPT-4o, Pepsi, personalized medicine, Pfizer, predictive models, privacy, PyTorch, Qualcomm Snapdragon, quantum computing, Rain Neuromorphics, reasoning algorithms, reasoning models, Reinforcement Learning from Human Feedback, remote work, RL, RLHF, robotics, RunwayML, Sakana AI, scientific discovery, self-driving cars, sepsis onset, SHAP, Siemens’ edge solutions, simulations, Slack, Smell data, softmax weights, support vector machines, sustainability, Sycamore, synthetic data, Tempus, TensorFlow, Tesla’s Full Self-Driving chips, TinyML, touch data, TPUs, traditional ML, transformers, TSMC, upskilling, ViT, VQA, VR, Wafer-Scale Engine, wearables, XAI

This interview with Grok, conducted between March 14 and 18, 2025, explored the multifaceted radical shifts AI is driving across the globe, reflecting RadicalShift.AI’s mission to obsessively observe these changes. We traversed a vast landscape—starting with AI’s implications for intellectual property, where it blurs ownership and challenges legal norms, to its ethical quandaries in military…
Continue Reading
analysesNVIDIA’s Role in Healthcare Innovation Feb 2025

Accelerated computing, Americas, Analytics, Artificial Intelligence, Big Data, Generative AI, Healthcare, Neural networks, Pharma & Biotech, Predictive analytics, Semiconductors

March 4, 2025

RadicalShift.AI

$10 trillion, 1993, 2025, AI, AlphaFold2, Amgen, Arc Institute, biologics, BioNeMo™, California, Clara, clinical trials, Cosmos Nemotron, CT, deCODE genetics, Deloitte, DGX Cloud, DGX SuperPOD, DGX systems, DiffDock 2.0, Drug Discovery, Freyja, genomics, GPUs, H100 Tensor Core GPUs, Healthcare, Iceland, Illumina, IQVIA, J.P. Morgan Healthcare Conference, Mayo Clinic, medical imaging, MONAI, MRI, NIM microservices, NVIDIA, Parabricks, precision medicine, ProteinMPNN, Quartz Atlas AI, RAPIDS, Reykjavik, RFdiffusion, Santa Clara, The Crick Team, TRACERx EVO, UC San Diego, ultrasound, Wellcome Sanger Institute

Key Points Nvidia is a tech leader in GPUs and AI, expanding into healthcare with innovative platforms. Partners with major healthcare firms like IQVIA, Illumina, Mayo Clinic, and Amgen for AI-driven solutions. Impacts drug discovery, medical imaging, genomics, and clinical trials, accelerating research and improving outcomes. Surprisingly, Nvidia’s AI helps predict protein properties for biologics,…
Continue Reading
individualsJensen Huang: Visionary Leader Powering the GPU and AI Revolution

Accelerated computing, AI accelerators, AI Inference, Algorithms, Americas, Artificial Intelligence, Asia, Automation, Automotive, Autonomous driving, Cloud, Computer vision, Data centers, Deep learning, Defence, Electronics & Machinery, Entertainment, Gaming, Generative AI, Graph neural network (GNN), Graphics Processing Unit (GPU), Healthcare, Infrastructure & Utilities, Internet & Online, Machine intelligence, Machine learning, Management, Neural networks, Pharma & Biotech, Robotics, Science, Semiconductors, Society, Supercomputer

February 26, 2025

Oleg Lazarov

accelerated computing, AI, AI revolution, Ampere, autonomous vehicles, chip design, Chris Malachowsky, corporate culture, CUDA, Curtis Priem, Data Centers, deep learning, Denny’s, founder-led company, GeForce 256, GPU, GPU computing, Grace CPU, high-performance computing, Hopper, HPC, Huang’s Law, immigrant entrepreneurship, innovation, Jensen Huang, leadership philosophy, Mellanox, NVIDIA, parallel processing, Silicon Valley, strategic acquisitions, strategic decisions, tech visionary, Volta

Jensen Huang is the co-founder, President, and CEO of NVIDIA, a company he started in 1993 that has grown from a niche graphics chip producer into a dominant force in artificial intelligence (AI) and high-performance computing. Huang’s journey – from a young immigrant washing dishes at Denny’s to the leader of a trillion-dollar tech company…
Continue Reading
newsMeta Unveils Breakthroughs in Brain Language Decoding and AI’s Role in Healthcare Innovation

AI assistants, AI models, Algorithms, Americas, Analytics, Artificial Intelligence, Healthcare, Pharma & Biotech

February 8, 2025

Sheryl Rivera

AI, AI in healthcare, AI model, AMI, Basque Center on Cognition, brain activity, Brain and Language, Brain-Computer Interfaces, breakthroughs, BrightHeart, CEA, CNRS, DINOv2, dynamic neural code, EEG, ENS-PSL, FAIR lab, FDA clearance, human intelligence, Inria, language production, MEG, Meta, neural code, neuroscience, NeuroSpin, non-invasive brain recording, open-source, Rothschild Foundation, San Sebastián, sentence decoding, Spain, Virgo

MENLO PARK — Meta’s Fundamental Artificial Intelligence Research (FAIR) lab in Paris has long been a leader in scientific innovation, contributing significant advances across multiple fields, including medicine, climate science, and conservation. As the lab continues to focus on developing advanced machine intelligence (AMI), it is also dedicated to driving innovation that can benefit society…
Continue Reading
newsBioptimus Secures $76M to Unlock the Future of AI-Driven Biology

AI accelerators, AI models, Algorithms, Artificial Intelligence, Cybersecurity, Data, Europe, Generative pre-trained transformers (GPT), Graphics Processing Unit (GPU), Pharma & Biotech, Science

February 7, 2025

Sheryl Rivera

$76M funding, AI foundation model, AI in healthcare, AI model development, AI-powered biology, biological data integration, biology AI, Bioptimus, biotech industry, biotech innovation, biotechnology, Cathay Innovation, future of biology research, gene expression, H-Optimus-0, Jacky Abitbol, Jean-Philippe Vert, medical research, multi-scale AI model, ovarian cancer, pathology, pharmaceutical industry, Sofinnova Partners

PARIS — Bioptimus, a trailblazer in AI foundation models for biology, has successfully raised $76 million in funding, marking a significant milestone for the company. This total includes a $41 million investment led by Cathay Innovation, with participation from prominent investors such as Sofinnova Partners, Bpifrance, Andera Partners, Hitachi Ventures, Boom Capital Ventures, Sunrise, and…
Continue Reading
newsQuantum Computing Inc. Partners with Sanders TDI to Advance Drug Discovery with Quantum Technology

Americas, Artificial Intelligence, Pharma & Biotech, Quantum Computing, Supercomputer

January 16, 2025

Sheryl Rivera

biomolecular modeling, cloud-based access, computational biomedicine, computational chemistry, Dirac-3 Entropy Quantum Computing Machine, Drug Discovery, Kettering Cancer Center, Memorial Sloan Weill Cornell Medicine, optimization problems, QCi, quantum analog computers, quantum computation, Quantum Computing Inc, quantum optics, quantum technologies, Sanders TDI, Sanders Tri-Institutional Therapeutics Discovery Institute, targeted therapeutics, The Rockefeller University

HOBOKEN, NJ — Quantum Computing Inc. (QCi), a leader in integrated photonics and quantum optics technology, has announced an exciting new collaboration with the Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. (Sanders TDI) to advance research in computational biomedicine. This partnership will leverage QCi’s cutting-edge quantum computation technology, particularly its Dirac-3 Entropy Quantum Computing Machine, to…
Continue Reading
newsEMBL and ELLIS Partner to Lead Europe in AI-Powered Life Sciences Innovation

AI assistants, AI models, Algorithms, Analytics, Artificial Intelligence, Automation, Autonomous driving, Europe, Healthcare, Industrial, Machine learning, Pharma & Biotech

January 14, 2025

Sheryl Rivera

AI, AI innovation, AI Models, AI researchers, AI-driven breakthroughs, AI-powered advancements, AlphaFold, Bernhard Schölkopf, biodata archives, Brussels, competitive innovation, data infrastructures, data resources, early-career scientists, Edith Heard, ELLIS, ELLIS Unit Heidelberg, EMBL, EMBL-EBI, Europe, European Bioinformatics Institute, European Molecular Biology Laboratory, global challenges, Heidelberg, human health, interdisciplinary collaboration, interdisciplinary training, joint research ventures, life sciences, life sciences research, machine learning, Memorandum of Understanding, MoU, planetary health, researcher mobility, scientific community, scientific discovery, scientific exchange, scientific models, scientific progress, Shaping Europe’s AI Leadership, training initiatives, transformative solutions

BRUSSELS — A new collaboration between the European Molecular Biology Laboratory (EMBL) and ELLIS is set to position Europe at the forefront of AI-driven breakthroughs in life sciences research. The two organizations have signed a Memorandum of Understanding (MoU), which will foster interdisciplinary training and the development of innovative projects aimed at addressing critical challenges…
Continue Reading
newsTU Dresden’s Clinical AI Research Group Leverages Llama Models to Revolutionize Cancer Care and Healthcare Innovation

AI assistants, AI models, Algorithms, Americas, Analytics, Artificial Intelligence, Education, Europe, Healthcare, LLMs (Large Language Models), Pharma & Biotech

January 8, 2025

Sheryl Rivera

agent-based approaches, AI deployment, AI in healthcare, anonymization, Clinical AI research group, clinical decision-making, clinical workflows, computational innovation, data security, deep learning, Else Kröner Fresenius Center for Digital Health, healthcare institutions, hospital hardware, Hugging Face, large language models, Llama 3.1, llama.cpp, medical coding, medical data, medical documents, medical jargon, medical professionals, multilingual capabilities, patient data, patient outcomes, personalized patient care, precision oncology, real-time clinical data, research, structured data, TUD Dresden University of Technology

MENLO PARK — TUD Dresden University of Technology is at the forefront of innovation in healthcare through its Clinical AI research group at the Else Kröner Fresenius Center for Digital Health. The group is transforming cancer care by applying cutting-edge computational techniques, particularly in precision oncology. Their work focuses on enhancing clinical decision-making by using…
Continue Reading
newsBenevolentAI Announces Strategic Realignment to Refocus on Core Mission and Long-Term Growth

AI assistants, AI models, Algorithms, Americas, Analytics, Artificial Intelligence, Investment, Management, Pharma & Biotech, Science

December 12, 2024

Oleg Lazarov

AI solutions, AI-powered drug discovery, AstraZeneca collaboration, balance sheet risk, BenevolentAI, biopharma innovation, biopharmaceutical development, clinical-stage programs, commercial partnerships, Cost reduction, cost savings, drug development lifecycle, entrepreneurial leadership, Euronext Amsterdam delisting, FDA-approved drug, financial runway 2027, IND readiness, industry adoption, Kenneth Mulvany, modular AI products, operational efficiency, operational flexibility, patient outcomes, Peter Allen, Phase 2 readiness, pre-IND assets, shareholder engagement, strategic transformation, streamlined operations, sustainable growth, TechBio mission, Technology Integration, UK Collective Consultation for Redundancy Rules, workforce reshaping

LONDON — BenevolentAI, a leader in AI-powered biopharmaceutical innovation, has announced a significant strategic transformation to realign the company with its foundational TechBio mission. This overhaul prioritizes core technology strengths, streamlines operations, and ensures sustainable growth through a more focused business model. Key changes include substantial cost reductions, an evaluation of delisting from Euronext Amsterdam,…
Continue Reading
newsNVIDIA’s MONAI Integration Advances Medical Imaging AI with New Deployable Microservices

AI models, Algorithms, Americas, Analytics, Artificial Intelligence, Generative AI, Healthcare, Machine learning, Open Source LLMs, Pharma & Biotech

December 3, 2024

Oleg Lazarov

AI, AI-assisted annotation, Alara Imaging, AWS HealthImaging, Axel Heitland, clinical practice, cloud service providers, CT image segmentation, digital marketplace, Flywheel, foundation models, German Cancer Research Center, Google Cloud, GSK, Healthcare, Hugging Face, Kitware, MAISI, MathWorks, Medical AI for Synthetic Imaging, medical imaging, medical imaging toolbox, Memorial Sloan Kettering Cancer Center, MICCAI challenge, Microsoft cloud, Model Zoo, MONAI, MONAI Deploy, MONAI Label, MONAI v1.4, NIM microservices, NVIDIA, NVIDIA NIM Microservices, Oracle Cloud Infrastructure, RadImageNet, research, Siemens Healthineers, University of Colorado School of Medicine, VISTA-2D, VISTA-3D

SANTA CLARA — At the SC24 conference, NVIDIA unveiled the latest innovation in AI for medical imaging with the announcement of new MONAI integration on Siemens Healthineers’ Digital Marketplace. This integration enables seamless delivery of AI-driven solutions to clinical workflows, enhancing the speed and efficiency of deploying AI models for medical imaging predictions. MONAI, NVIDIA’s…
Continue Reading
newsNVIDIA Unveils Open-Source BioNeMo Framework to Transform Drug Discovery and Biomolecular Research

AI assistants, AI models, Americas, Artificial Intelligence, Cloud, Datasets, Healthcare, Pharma & Biotech, Science, Semiconductors

November 19, 2024

Oleg Lazarov

AI research, AI tools, AlphaFold2, Argonne National Laboratory, biomolecular science, BioNeMo Blueprints, BioNeMo Framework, BioNeMo platform, biotechnology, cuEquivariance, DiffDock 2.0, digital biology, Drug Discovery, Dyno Therapeutics, Genentech, Ginkgo Bioworks, Kimberly Powell, molecular design, molecular modeling, NVIDIA, NVIDIA NIM™, open-source platform, pharmaceutical industry, ProteinMPNN, RFdiffusion, SC24, scalable AI deployments, supercomputing capabilities, virtual screening, Weights & Biases

SANTA CLARA — At SC24, NVIDIA announced the launch of its open-source BioNeMo Framework, a cutting-edge platform enabling global leaders in pharmaceuticals, biotechnology, and AI research to advance biomolecular science and accelerate drug discovery. Designed to address the challenges of scaling AI models in biomolecular research, BioNeMo brings supercomputing capabilities to biopharma, empowering researchers with…
Continue Reading
newsGluFormer: AI Model Predicts Glucose Levels and Health Outcomes, Paving the Way for Precision Medicine

AI models, Americas, Artificial Intelligence, Generative AI, Healthcare, Pharma & Biotech

November 14, 2024

Oleg Lazarov

AI model, AI technology, apnea-hypopnea index, clinical trial outcomes, continuous glucose monitoring, diabetes, diabetes prevention, diabetes statistics, dietary intake data, economic impact of diabetes, Gal Chechik, gestational diabetes, glucose levels, GluFormer, Guy Lutsker, health metrics, health outcomes, Human Phenotype Project, medical predictions, NVIDIA, NVIDIA Tensor Core GPUs, obesity, Pheno.AI, precision nutrition, prediabetes, predictive healthcare, sleep apnea, systolic blood pressure, transformer architecture, type 1 diabetes, type 2 diabetes, visceral adipose tissue, Weizmann Institute of Science

SANTA CLARA — Researchers from the Weizmann Institute of Science, Tel Aviv-based Pheno.AI, and NVIDIA have collaborated to develop GluFormer, a cutting-edge AI model designed to predict an individual’s glucose levels and other health metrics. This model uses past continuous glucose monitoring data to forecast future health outcomes, offering significant potential for both patients and…
Continue Reading
newsNVIDIA Powers Japan’s Healthcare Innovation with AI-Driven Advances in Drug Discovery, Genomics, and Medical Imaging

AI assistants, AI models, Americas, Artificial Intelligence, Asia, Data centers, Deep learning, Generative AI, Healthcare, LLMs (Large Language Models), Pharma & Biotech, Robotics, Supercomputer

November 12, 2024

Sheryl Rivera

aging population, AI, Astellas Pharma, CT imaging, Daiichi-Sankyo, DGX supercomputer, digital health, Drug Discovery, Fujifilm, genome sequencing, genomics, H100 Tensor Core GPUs, healthcare innovation, healthcare robotics, Holoscan, IOWN network, Japan, Jetson Orin modules, medical imaging, medical technology, Mitsui & Co, MONAI, NTT, NURA, NVIDIA, NVIDIA AI Summit Japan, NVIDIA BioNeMo, Olympus, Ono Pharmaceutical, Parabricks, precision medicine, Showa University, sovereign AI, surgical microscopy, Tokyo-1, University of Tokyo Human Genome Center, Xeureka

SANTA CLARA — Japan’s healthcare sector is embracing sovereign AI solutions to advance drug discovery, genomics, and medical device development, as healthcare providers and researchers innovate to meet the needs of an aging population. Nearly 30% of Japan’s citizens are over 65, and AI-driven healthcare is seen as vital to addressing an anticipated shortfall of…
Continue Reading
newsNVIDIA-Enabled AI and Confidential Computing Propel Mitsui’s Xeureka in Revolutionizing Drug Discovery

AI assistants, AI models, Americas, Artificial Intelligence, Asia, Generative AI, Healthcare, LLMs (Large Language Models), Pharma & Biotech, Supercomputer

November 12, 2024

Oleg Lazarov

AI, AI platform, AI supercomputer, autonomous trucking, chemical behaviors, confidential computing, data security, data sharing, digital transformation, Drug Discovery, Fortanix, geospatial analytics, global pharma, Healthcare, Hiroki Makiguchi, Japan, Katsuya Ito, large language models, ligand-base pairs, Mitsui & Co, molecular simulations, NVIDIA, NVIDIA BioNeMo, NVIDIA H100 Tensor Core GPUs, pharmaceutical industry, pharmaceutical R&D, predictive accuracy, protein structure prediction, quantum computing, Tokyo-1, Xeureka

SANTA CLARA — Mitsui & Co., a major Japanese conglomerate, is advancing drug discovery through its new subsidiary, Xeureka, which utilizes NVIDIA’s AI platform to securely harness shared datasets. Founded 77 years ago, Mitsui continues to innovate across its 16 divisions with digital transformation initiatives, ranging from autonomous trucking to geospatial analytics and even quantum…
Continue Reading
newsSimBioSys, Powered by NVIDIA AI, Launches 3D Imaging Technology to Transform Breast Cancer Surgery and Treatment

AI assistants, AI models, Algorithms, Americas, Analytics, Artificial Intelligence, Automation, Generative AI, Healthcare, Pharma & Biotech

October 31, 2024

Sheryl Rivera

3D imaging technology, AI-powered healthcare, breast cancer treatment, cancer recurrence risk analysis, CUDA-X libraries, medical imaging, MONAI, MRI, NVIDIA A100 Tensor Core GPUs, NVIDIA AI, NVIDIA Inception, SimBioSys, surgery planning, TumorSight Viz, volumetric imaging

SANTA CLARA — SimBioSys, an Illinois-based startup, has developed an advanced AI-powered imaging technology that creates highly accurate 3D models of tumors, veins, and other soft tissue, offering surgeons an innovative approach to breast cancer treatment. The technology, known as TumorSight Viz, transforms standard black-and-white MRI scans into volumetric images with color-coded components—highlighting veins, tumors,…
Continue Reading
newsGoogle DeepMind’s Demis Hassabis and John Jumper Win Nobel Prize in Chemistry for AlphaFold Breakthrough

AI assistants, Analytics, Artificial Intelligence, Chemicals, Europe, Healthcare, Machine learning, Pharma & Biotech, Science

October 9, 2024

Sheryl Rivera

2024 Nobel Prize, AI, AlphaFold, AlphaFold Protein Structure Database, artificial intelligence, computational protein design, David Baker, DeepMind, Demis Hassabis, Drug Discovery, enzyme design, Google, Google DeepMind, groundbreaking discoveries, Isomorphic Labs, John Jumper, Nobel Prize in Chemistry, protein structure prediction, Royal Swedish Academy of Sciences, scientific research

LONDON — Demis Hassabis, Co-founder and CEO of Google DeepMind and Isomorphic Labs, and Dr. John Jumper, Director at Google DeepMind, have been jointly awarded the 2024 Nobel Prize in Chemistry for their pioneering work on AlphaFold, an AI system capable of accurately predicting the three-dimensional structure of proteins from their amino acid sequences. They…
Continue Reading
newsGoogle DeepMind Unveils AlphaProteo: AI-Driven Protein Design System for Advancing Health and Biological Research

AI assistants, Algorithms, Americas, Analytics, Artificial Intelligence, Deep learning, Europe, Healthcare, Machine learning, Pharma & Biotech, Science

September 5, 2024

Sheryl Rivera

AI, AlphaFold, AlphaProteo, binding affinity, bioengineering, biological processes, biological research, biosecurity, diagnostics, disease mitigation, drug design, Francis Crick Institute, Google DeepMind, health research, IL-7Rɑ, PD-L1, protein binders, Protein Data Bank, protein design, Protein Design team, SARS-CoV-2, sustainable manufacturing, TNFɑ, VEGF-A, Wet Lab team

LONDON — Google DeepMind recently announced AlphaProteo, a pioneering AI-driven system designed to generate novel protein binders with applications in biology and health research. Created by DeepMind’s Protein Design and Wet Lab teams, AlphaProteo stands out as the first AI tool capable of designing effective protein binders for targets like VEGF-A, a protein linked to…
Continue Reading
newsRevolutionizing Cardiac Care: Philips Unveils AI-Powered Solutions at Heart Rhythm Annual Meeting

Algorithms, Analytics, Artificial Intelligence, Automation, Europe, Healthcare, Pharma & Biotech

May 17, 2024

Sheryl Rivera

AEX: PHIA, AI and deep neural network (DNN) algorithms, AI-powered cardiac care solutions, AI-powered data platform, arrhythmia events, Boston, cardiovascular disease, CIED infection, clinical and economic benefits, cost-effectiveness, Dr. David Lin, Dr. Mohammad-Ali Jazayeri, ECG, electrophysiologist, EP-COT Trial, health technology, Heart Rhythm Annual Meeting, implantable loop recorders, Manish Wadhwa, May 16-19, MCOT, Medtronic, mobile cardiac monitoring technology, NYSE: PHG, Philips, Philips Ambulatory Monitoring & Diagnostics, retrospective study results, Rhythm Theater, Royal Philips, stroke patients, syncope, wearable ECG sensor

AMSTERDAM — Royal Philips, a pioneer in health technology, took center stage at the Heart Rhythm Annual Meeting in Boston (May 16-19), presenting groundbreaking research on the clinical and economic benefits of its AI-driven cardiac care solutions. With cardiovascular disease posing a growing threat, the need for efficient and cost-effective care has never been more…
Continue Reading
newsEmpowering Biopharma Innovation: Sartorius Expands Collaboration with NVIDIA for AI-driven Therapeutic Advancements

Algorithms, Americas, Analytics, Artificial Intelligence, Automation, Edge computing, Europe, Healthcare, Pharma & Biotech, Predictive analytics

May 16, 2024

Sheryl Rivera

3D-bioprinted spheroids, AI-powered computing platforms, biopharmaceutical, bioprocess design, bioprocessing, Clara suite, Drug Discovery, innovative therapies, laboratory instruments, life sciences, NVIDIA, organoids, precision medicine, predictive AI models, Prof. Dr. Oscar-Werner Reif, Sartorius, synthetic biological pathways, XETRA

GÖTTINGEN — Sartorius, a renowned life science group, is embarking on an expanded collaboration with NVIDIA, a leader in AI-powered computing platforms, to drive the development of new and improved therapies. This collaboration aims to merge Sartorius’ profound expertise in life sciences and bioprocessing with NVIDIA’s cutting-edge AI technologies to expedite biopharma drug discovery and…
Continue Reading
newsGoogle DeepMind Unveils AlphaFold 3 to Revolutionize Molecular Biology and Drug Discovery

AI assistants, Algorithms, Americas, Analytics, Artificial Intelligence, Europe, Healthcare, Machine learning, Pharma & Biotech

May 8, 2024

Sheryl Rivera

agriculture, AI model, AlphaFold 2, AlphaFold 3, AlphaFold Server, biological functions, biomolecular structures, cancer therapies, cell biology, DNA, Drug Discovery, environmental science, enzyme development, free access, genomics, Google DeepMind, health, Isomorphic Labs, ligands, molecular complexes, molecular interactions, pharmaceutical partners, precision medicine, proteins, RNA, sustainability, therapeutics, vaccine research

LONDON — Google DeepMind and Isomorphic Labs have unveiled AlphaFold 3, an innovative AI model that advances the understanding of molecular structures and interactions. Expanding on the success of AlphaFold 2, this new model predicts how proteins, DNA, RNA, ligands, and other biomolecules fit and interact, achieving up to a 50% accuracy increase in interaction…
Continue Reading

What is RadicalShift AI?

RadicalShift.ai represents the paradigm shift the artificial intelligence (AI) brings upon all of us, from the way we live and work to the way we do business. To help cope with these fundamental changes across life, industries and the world in general, we are obsessively observing (30+ markets across multiple continents) and covering the AI industry while building a scalable open platform aimed at people, businesses and industry stakeholders to contribute across (benefit from) the entire spectrum of the AI industry from news, views, insights to knowledge, deployments, entities, people, products, tools, jobs, investors, pitch decks, and beyond, helping build what would potentially be a resourceful, insightful, knowledgeable and analytical source for AI related news, information and resources, ultimately becoming the AI industry graph/repository.

AI.RadicalShift

Category: Pharma & Biotech

interviewsVery Long Interview with Grok 3 on AI: The Great Handover: How AI is Reshaping Our World

analysesNVIDIA’s Role in Healthcare Innovation Feb 2025

individualsJensen Huang: Visionary Leader Powering the GPU and AI Revolution

newsMeta Unveils Breakthroughs in Brain Language Decoding and AI’s Role in Healthcare Innovation

newsBioptimus Secures $76M to Unlock the Future of AI-Driven Biology

newsEMBL and ELLIS Partner to Lead Europe in AI-Powered Life Sciences Innovation

newsTU Dresden’s Clinical AI Research Group Leverages Llama Models to Revolutionize Cancer Care and Healthcare Innovation

newsBenevolentAI Announces Strategic Realignment to Refocus on Core Mission and Long-Term Growth

newsNVIDIA Unveils Open-Source BioNeMo Framework to Transform Drug Discovery and Biomolecular Research

newsGluFormer: AI Model Predicts Glucose Levels and Health Outcomes, Paving the Way for Precision Medicine

newsNVIDIA Powers Japan’s Healthcare Innovation with AI-Driven Advances in Drug Discovery, Genomics, and Medical Imaging

newsSimBioSys, Powered by NVIDIA AI, Launches 3D Imaging Technology to Transform Breast Cancer Surgery and Treatment

newsGoogle DeepMind’s Demis Hassabis and John Jumper Win Nobel Prize in Chemistry for AlphaFold Breakthrough

newsGoogle DeepMind Unveils AlphaProteo: AI-Driven Protein Design System for Advancing Health and Biological Research

newsRevolutionizing Cardiac Care: Philips Unveils AI-Powered Solutions at Heart Rhythm Annual Meeting

newsEmpowering Biopharma Innovation: Sartorius Expands Collaboration with NVIDIA for AI-driven Therapeutic Advancements

newsGoogle DeepMind Unveils AlphaFold 3 to Revolutionize Molecular Biology and Drug Discovery

What is RadicalShift AI?

Latest Entries

🏭 INDUSTRIES / MARKETS:

🏷️ TAGS

📂 ARCHIVE